<DOC>
	<DOCNO>NCT01727726</DOCNO>
	<brief_summary>To compare efficacy brexpiprazole ( flexible dose ) placebo adjunctive therapy assign open label antidepressant therapy ( ADT ) propose subject population MDD .</brief_summary>
	<brief_title>A Study Flexible-dose Brexpiprazole Adjunctive Therapy Treatment Adults With Major Depressive Disorder , Delphinus Trial</brief_title>
	<detailed_description>This trial design assess safety efficacy brexpiprazole ( flexible dose ) adjunctive therapy assign know anti-depressant depressed subject . The trial consist continuous 18-week double-blind treatment period 30-day follow-up . Subjects complete trial visit Week 18 visit may offer entry optional open-label rollover trial .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Mood Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>Male female outpatient 18 65 year age , inclusive , time informed consent . Subjects diagnosis MDD , current major depressive episode , define DSMIVTR criterion Subjects willing discontinue prohibit psychotropic medication meet protocolrequired washout prior trial period . Females breastfeed and/or positive pregnancy test result screen prior receive trial medication Subject current Axis I ( DSMIVTR ) diagnosis : dementia , Schizophrenia , Bipolar , Eating disorder , Obsessivecompulsive disorder , Panic disorder , Posttraumatic stress disorder Subjects experience hallucination , delusion psychotic symptomatology current major depressive episode . Subjects meet DSMIVTR criterion substance abuse dependence within past 180 day Subjects currently treat insulin diabetes . Subjects uncontrolled hypertension Subjects know ischemic heart disease history myocardial infarction , congestive heart failure , angioplasty , stenting , coronary artery bypass Surgery Subjects positive drug screen cocaine , marijuana , illicit drug Inability swallow tablet tolerate oral medication Abnormal laboratory test result , vital sign ECG result Subjects previously participate prior brexpiprazole clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>OPC-34712</keyword>
	<keyword>brexpiprazole</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Adjunctive Treatment</keyword>
</DOC>